| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/02/2009 | US20090170890 Methohds of inhibiting viral infection |
| 07/02/2009 | US20090170882 Methods and compositions |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170861 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors |
| 07/02/2009 | US20090170859 Viral Polymerase Inhibitors |
| 07/02/2009 | US20090170856 Heterocyclic antiviral compounds |
| 07/02/2009 | US20090170855 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170846 Inhibitors of the hiv integrase enzyme |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170812 Transcription factor modulating compounds and methods of use thereof |
| 07/02/2009 | US20090170806 Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350 |
| 07/02/2009 | US20090170805 Anti-microbial agents and uses thereof |
| 07/02/2009 | US20090170791 Macrolones |
| 07/02/2009 | US20090170790 Ketolide derivatives as antibacterial agents |
| 07/02/2009 | US20090170783 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 07/02/2009 | US20090170764 Compositions containing anti-hiv peptides and methods for use |
| 07/02/2009 | US20090170755 Cyclic Peptide Compounds |
| 07/02/2009 | US20090170753 Capsofungin formulations |
| 07/02/2009 | US20090169644 Antidandruff Shampoo |
| 07/02/2009 | US20090169635 Pharmaceutical compositions and use thereof |
| 07/02/2009 | US20090169614 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/02/2009 | US20090169600 Hydrogen Peroxide Delivery System |
| 07/02/2009 | US20090169576 Influenza combinatorial antigen vaccine |
| 07/02/2009 | US20090169574 Heteroclitic analogs and related methods |
| 07/02/2009 | US20090169568 Antigenic Complex for the Diagnosis and Treatment of Porphyromonas Gingivalis Infection |
| 07/02/2009 | US20090169567 Basic group-containing compound and use thereof |
| 07/02/2009 | US20090169562 Human Binding Molecules Having Killing Activity Against Enterococci and Uses Thereof |
| 07/02/2009 | US20090169557 Whole glucan particles in combination with antibiotics, vaccines and viral monoclonal antibodies |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169511 Mucosal Bioadhesive SLow Release Carrier for Delivering Active Principles |
| 07/02/2009 | US20090169510 treating hepatitis by modulating NS3/NS4 protease comprising contacting a NS3/NS4 protease with a compound of the invention |
| 07/02/2009 | US20090169507 Purine nucleoside analogues for treating flaviviridae including hepatitis c |
| 07/02/2009 | US20090169504 Compounds and Pharmaceutical compositions for the treatment of Viral infections |
| 07/02/2009 | US20090169503 Dna-based vaccination of retroviral-infected individuals undergoing treatment |
| 07/02/2009 | CA2710644A1 Macrocyclic indoles as hepatitis c virus inhibitors |
| 07/02/2009 | CA2710600A1 Recombinant rsv antigens |
| 07/02/2009 | CA2710417A1 Glycosylated glycopeptide antibiotic derivatives |
| 07/02/2009 | CA2709884A1 Antimicrobial compounds |
| 07/02/2009 | CA2709664A1 Method for manufacturing heterocycle substituted pyridine derivatives |
| 07/02/2009 | CA2709500A1 Type iii secretion system component protein pa1698 of pseudomonas aeruginosa |
| 07/02/2009 | CA2709348A1 Heterocyclic antiviral compounds |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/01/2009 | EP2075258A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 07/01/2009 | EP2075005A1 Ipv-dpt vaccine |
| 07/01/2009 | EP2074998A2 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 07/01/2009 | EP2074889A1 Animal feed additive and animal feed |
| 07/01/2009 | EP2074221A2 Improved methods for the separation of streptococcus pneumoniae type 3 polysaccharides |
| 07/01/2009 | EP2074147A1 Antibodies against ccr5 and uses thereof |
| 07/01/2009 | EP2074124A1 3- (benzo [d][1,3]dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents |
| 07/01/2009 | EP2074111A2 Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents |
| 07/01/2009 | EP2074100A1 Biofilm-inhibiting effect and anti-infective activity of n,c-linked arylisoquinolines and the use thereof |
| 07/01/2009 | EP2074099A1 Quinolinone derivatives |
| 07/01/2009 | EP2074085A2 Anti-infective thiourea compounds |
| 07/01/2009 | EP2073847A2 Methods and materials for reducing risk of cold and/or flu |
| 07/01/2009 | EP2073838A1 Therapeutic vaccine comprising mycobacterial heat shock protein 70 |
| 07/01/2009 | EP2073830A1 Interferon type i supporting compounds |
| 07/01/2009 | EP2073828A2 Composition to treat or prevent gastrointestinal infection |
| 07/01/2009 | EP2073810A2 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile compound for treating diabetes, cancer, autoimmune disorders and hiv infection |
| 07/01/2009 | EP2073804A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 07/01/2009 | EP2005945A9 Oseltamivir phosphate granule and preparation mehtod thereof |
| 07/01/2009 | EP1707210A4 Antiviral preparation |
| 07/01/2009 | EP1697343B1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 07/01/2009 | EP1576159B1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/01/2009 | EP1552018B1 Methods and compositions relating to gene silencing |
| 07/01/2009 | EP1536833B1 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1377165B1 Tsg101-gag interaction and use thereof |
| 07/01/2009 | EP1322316B1 Diuretic or sulphonylurea for use in antiviral treatment |
| 07/01/2009 | EP1301486B1 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 07/01/2009 | EP1250154B1 G-csf conjugates |
| 07/01/2009 | EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 07/01/2009 | EP0784688B1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 07/01/2009 | CN101469017A Synthetic peptide vaccines for foot-and-mouth disease |
| 07/01/2009 | CN101469009A Methods and compositions for treating hepatitis c virus |
| 07/01/2009 | CN100506980C Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequence and their therapeutic use |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506825C Heterotricyclyl 6-alkylidene-penems as beta epsilontaualpha-lactamase inhibitors |
| 07/01/2009 | CN100506802C Formyl peptide-like acceptor-1 regulator and its Preparation and use |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
| 06/30/2009 | US7553962 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/30/2009 | US7553926 Therapeutic amino acid sequences for prevention and treatment of lymphadenopathy associated viral infection: viricides |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553839 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/30/2009 | US7553835 foam or mousse; antifungal such as ketoconazole, lower alcohol, fatty alcohol, a quaternary or ethoxylated sorbitan surfactant, water, hydrocarbon gas propellant; jock itch, tinea, dandruff and sebborheic dermatitis |
| 06/30/2009 | US7553826 Cytarabine monophosphate prodrugs |
| 06/30/2009 | US7553825 2-Amino,6-cyclopropyl,9-((bis(alkoxycarbonylalkylamino-)phosphinyl)-methoxyethyl-)purine;viricides; papilloma virus; urogental disorders; antiapoptosis; prodrugs; oral drug delivery; bioavailability |
| 06/30/2009 | US7553493 Chlamydia flagellar protein antigen |
| 06/30/2009 | US7553483 Chemokine mutants acting as chemokine antagonists |
| 06/30/2009 | CA2473076C Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones |
| 06/30/2009 | CA2459399C Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
| 06/30/2009 | CA2407468C Hydrates and crystals of a neuraminic acid compound |
| 06/30/2009 | CA2406833C Effervescent granules and methods for their preparation |
| 06/30/2009 | CA2324970C Improved immunodiagnostic assays using reducing agents |
| 06/30/2009 | CA2286399C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/30/2009 | CA2203480C Interferon conjugates |